ATFX Strengthens Strategic Engagements Across Key Financial Hubs
HONG KONG, March 2, 2026 /PRNewswire/ -- ATFX continues to expand its global footprint through strategic engagements across London, Miami and Dubai, highlighting its commitment to international collaboration and industry innovation. Through...
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment...